Developer docs
API playgroundTry for free, no card

Search company profiles

TruDiagnostic

Full company profile

uuid00008ox

Namestring
TruDiagnostic
Legal namestring
TruDiagnostic, LLC
Company typeenum
Private
Founded yearint
2019
Descriptiontext

TruDiagnostic is a privately held biodata and epigenetic diagnostics company founded in 2019 and headquartered in Lexington, Kentucky, with 51-100 employees. It operates a CLIA-certified, HIPAA-compliant laboratory and sells direct-to-consumer at-home biological age testing kits through its e-commerce storefront (shop.trudiagnostic.com), a healthcare provider portal for clinical practices, and an Impact-powered affiliate channel, with the TruAge™ test priced at $499 one-time or $179.90/year subscription and the TruHealth™ panel (105+ biomarkers) and combined bundle (180+ biomarkers) rounding out the catalog. The core technology is Illumina EPIC array-based DNA methylation analysis measuring over 100,000 CpG sites, which feeds a proprietary algorithm stack including OMICmAge (co-developed with Harvard University, integrating methylation with proteomic, metabolomic, and clinical data and validated across 36,000+ individuals), SYMPHONYAge (organ-specific aging across 11 body systems, from Yale University), and an exclusively licensed DunedinPACE pace-of-aging algorithm.

Short descriptiontext

TruDiagnostic is a private epigenetic diagnostics company that sells at-home DNA methylation-based biological age tests and biomarker panels to health-conscious consumers, healthcare providers, and academic researchers via proprietary algorithms co-developed with Harvard and Yale universities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLexington, United States
HQ citystring
Lexington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
epigenetic testing services, biological age testing, DNA methylation analysis, longevity diagnostics, at-home health tests
Industry4 codes
PRIMARYHLAGANAF
Epigenomics & Chromatin Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Epigenetic Testing Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Direct-to-Consumer Epigenetic Testing
TypeOne Time License
Description

One-time purchase of at-home test kits with results delivered via digital dashboard. Initial purchase at $499 with optional subscription at $179.90 for ongoing tracking and updates.

trudiagnostic.com
2Annual Subscription
TypeSubscription Recurring
Description

Subscription model for continued access to updated reports, longitudinal tracking, and new algorithm releases. All sales final per refund policy.

trudiagnostic.com
3Healthcare Provider Services
TypeProfessional Services
Description

B2B laboratory services for healthcare providers including patient epigenetic testing through provider portal with HIPAA-compliant data handling.

trudiagnostic.com
4NIH-Funded Research
TypeLicensing Royalties
Description

SBIR grant funding from National Institutes of Health for developing new epigenetic diagnostic models. Subject to NIH FCOI policy compliance.

trudiagnostic.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details4 tiers
1TruAge Test - One-time purchase
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$499 USD per test kit. Includes comprehensive epigenetic analysis, biological age score, pace of aging, organ system ages, and multiple biomarker reports.

shop.trudiagnostic.com
2TruAge Test - Annual Subscription
ModelSubscriptionBilling cadenceAnnual
Notes

$179.90 per year after initial purchase. Subscription available US only. Includes access to updated reports and longitudinal tracking capabilities.

shop.trudiagnostic.com
3TruHealth Test
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

TruHealth test measures 105+ biomarkers for nutritional and biological systems health including vitamins, antioxidants, fatty acids, amino acids, and toxins.

trudiagnostic.com
4TruAge + TruHealth Combo
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Bundle kit measuring 180+ biomarkers with both TruAge epigenetic analysis and TruHealth nutritional testing combined.

trudiagnostic.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 3 records shown
1TruAge™
Description

Epigenetic test measuring biological age at the cellular level, including OMICmAge, DunedinPACE, SYMPHONYAge, and various health risk assessments.

trudiagnostic.com
+2 more records
Core offering1 text field

TruDiagnostic sells at-home epigenetic and biomarker test kits—primarily the TruAge™ biological age test, the TruHealth™ nutritional/biological systems test, and a combined bundle—processed in its CLIA-certified Lexington, Kentucky laboratory using Illumina EPIC array DNA methylation analysis. It also provides B2B clinical laboratory services to healthcare providers, research collaborations to academic institutions, and grant-funded research to develop new epigenetic diagnostic models. The company operates what it describes as the world's largest private DNA methylation dataset and licenses/exclusively licenses proprietary algorithms (OMICmAge, DunedinPACE, SYMPHONYAge) to power its reports.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 32-week semaglutide study showed average biological age reversal of 3.1 years and 9% slowing of aging rate
+1 more record
Product overview1 text field

TruDiagnostic offers a multi-tiered platform of epigenetic testing products designed for at-home biological age assessment and longevity tracking. The core offerings include TruAge™ (epigenetic biological age testing), TruHealth™ (nutritional and systems health testing), and their combined bundle. TruAge measures biological age using proprietary algorithms including OMICmAge™ (developed with Harvard University), DunedinPACE™ (exclusively licensed), and SYMPHONYAge™ (from Yale University), analyzing over 100,000 DNA methylation markers. TruHealth complements this with 105+ biomarkers for nutritional, metabolic, immune, and cognitive health assessment. The platform is CLIA certified, HSA/FSA accepted, and designed for direct-to-consumer use with at-home sample collection kits priced at $499 for TruAge with subscription options available.

Product and service1 record
1TruAge™ Test
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-13
Description

Exclusive Australian partnership where TMRW longevity platform provides TruDiagnostic's epigenetic testing services to Australian members. TruDiagnostic gains market access while TMRW offers comprehensive longevity diagnostics.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative development of OMICmAge, a multi-omic biological aging biomarker that integrates DNA methylation with proteomic, metabolomic, and clinical data. Partnership leverages Harvard research expertise with TruDiagnostic's proprietary database.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Licensing and development of SYMPHONYAge clock series providing organ-specific epigenetic aging algorithms across 11 body systems including brain, heart, liver, and lungs.

4Dunededin Study (University of Otago)
Strategic tierCoreTypeTechnology or Integration
Description

Exclusively licensed DunedinPACE algorithm from the Dunedin Multidisciplinary Health and Development Study for pace of aging measurement.

trudiagnostic.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration to fully characterize all imprinting control regions and develop novel Imprintome epigenetic methylation array for testing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University partnership for research and licensing opportunities in epigenetics and aging research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University partnership for research and licensing opportunities in epigenetics and aging research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Active partnerships with over 20 renowned universities for research collaborations and licensing opportunities in epigenetic science.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Elysium's Index product is a direct-to-consumer epigenetic age test built on Illumina EPIC arrays—the closest head-to-head competitor to TruDiagnostic's TruAge. Both compete for the same biohacker and longevity consumer with methylation-based biological age reports.

TypeDirect peer
Description

Tally Health offers a consumer longevity membership with biological age testing and clinical protocols. It was acquired by TruDiagnostic in April 2026, but operationally its consumer offering is structurally identical to TruDiagnostic's DTC longevity positioning.

TypeDirect peer
Description

NOVOS sells longevity supplements bundled with a biological age testing program including epigenetic measures. It targets the same biohacker and longevity consumer with a combined supplement-and-test value proposition that overlaps with TruDiagnostic's wellness-oriented customer base.

TypeDirect peer
Description

GlycanAge offers a direct-to-consumer biological age test based on immunoglobulin G glycan analysis. It competes for the same longevity-conscious consumer seeking objective biological age measurement, using a complementary but substitutable biomarker approach to DNA methylation.

TypeDirect peer
Description

InsideTracker provides personalized biomarker analysis from blood tests with longevity and performance-oriented dashboards. It competes with TruDiagnostic's TruHealth panel for consumers seeking data-driven health optimization, though its core modality is blood biomarkers rather than epigenetics.

6Function Health
TypeEmerging player
Description

Function Health offers comprehensive annual blood biomarker testing with a longevity framing and physician-led review. It addresses a similar health-optimization consumer with broader lab panels, making it a partial substitute for TruDiagnostic's premium testing bundles.

TypeEmerging player
Description

Viome sells direct-to-consumer gut microbiome and transcriptomic testing with personalized nutrition recommendations and a 'biological age' framing. It overlaps with TruDiagnostic's preventive-health, multi-omic consumer value proposition though its core analyte is the microbiome.

TypeBroad incumbent
Description

Human Longevity offers whole-genome sequencing, advanced imaging, and comprehensive biomarker panels in a premium executive-health membership. It overlaps with TruDiagnostic's premium longevity diagnostics segment with a broader (and more expensive) clinical-grade offering.

TypeBroad incumbent
Description

Genova Diagnostics is an established specialty clinical laboratory offering advanced biomarker, genomic, and functional testing through healthcare providers. It competes for TruDiagnostic's healthcare-provider channel with a deeper, more clinically entrenched footprint.

TypeOthers
Description

Zymo Research supplies epigenetic research reagents, kits, and services (including DNA methylation arrays and analysis) used by academic and clinical labs. It is an enabling technology provider in the same epigenetic workflow that TruDiagnostic's lab depends on, rather than a direct consumer competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TruDiagnostic

Epigenetic Testing Servicestrudiagnostic.com

TruDiagnostic is a private epigenetic diagnostics company that sells at-home DNA methylation-based biological age tests and biomarker panels to health-conscious consumers, healthcare providers, and academic researchers via proprietary algorithms co-developed with Harvard and Yale universities.

What TruDiagnostic does

TruDiagnostic is a privately held biodata and epigenetic diagnostics company founded in 2019 and headquartered in Lexington, Kentucky, with 51-100 employees. It operates a CLIA-certified, HIPAA-compliant laboratory and sells direct-to-consumer at-home biological age testing kits through its e-commerce storefront (shop.trudiagnostic.com), a healthcare provider portal for clinical practices, and an Impact-powered affiliate channel, with the TruAge™ test priced at $499 one-time or $179.90/year subscription and the TruHealth™ panel (105+ biomarkers) and combined bundle (180+ biomarkers) rounding out the catalog. The core technology is Illumina EPIC array-based DNA methylation analysis measuring over 100,000 CpG sites, which feeds a proprietary algorithm stack including OMICmAge (co-developed with Harvard University, integrating methylation with proteomic, metabolomic, and clinical data and validated across 36,000+ individuals), SYMPHONYAge (organ-specific aging across 11 body systems, from Yale University), and an exclusively licensed DunedinPACE pace-of-aging algorithm.

TruDiagnostic firmographics

Firmographics
Name
TruDiagnostic
Legal name
TruDiagnostic, LLC
Website
https://trudiagnostic.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
TruDiagnostic is a private epigenetic diagnostics company that sells at-home DNA methylation-based biological age tests and biomarker panels to health-conscious consumers, healthcare providers, and academic researchers via proprietary algorithms co-developed with Harvard and Yale universities.
Ownership category
akta.pro rank

TruDiagnostic industry classification

Industry
Product category
Epigenetic Testing Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAF
Epigenomics & Chromatin Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Epigenetic testing services
  • Biological age testing
  • DNA methylation analysis
  • Longevity diagnostics
  • At-home health tests

Where TruDiagnostic is headquartered

Location

Headquarters

HQ city
Lexington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

TruDiagnostic business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Direct-to-Consumer Epigenetic Testing: One-time purchase of at-home test kits with results delivered via digital dashboard. Initial purchase at $499 with optional subscription at $179.90 for ongoing tracking and updates.
  2. Annual Subscription: Subscription model for continued access to updated reports, longitudinal tracking, and new algorithm releases. All sales final per refund policy.
  3. Healthcare Provider Services: B2B laboratory services for healthcare providers including patient epigenetic testing through provider portal with HIPAA-compliant data handling.
  4. NIH-Funded Research: SBIR grant funding from National Institutes of Health for developing new epigenetic diagnostic models. Subject to NIH FCOI policy compliance.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goTruAge Test - One-time purchase
SubscriptionAnnualTruAge Test - Annual Subscription
One time/ perpetual licensePay-as-you-goTruHealth Test
One time/ perpetual licensePay-as-you-goTruAge + TruHealth Combo

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

TruDiagnostic product offering

Product offering

Core offering

TruDiagnostic sells at-home epigenetic and biomarker test kits—primarily the TruAge™ biological age test, the TruHealth™ nutritional/biological systems test, and a combined bundle—processed in its CLIA-certified Lexington, Kentucky laboratory using Illumina EPIC array DNA methylation analysis. It also provides B2B clinical laboratory services to healthcare providers, research collaborations to academic institutions, and grant-funded research to develop new epigenetic diagnostic models. The company operates what it describes as the world's largest private DNA methylation dataset and licenses/exclusively licenses proprietary algorithms (OMICmAge, DunedinPACE, SYMPHONYAge) to power its reports.

Product overview

TruDiagnostic offers a multi-tiered platform of epigenetic testing products designed for at-home biological age assessment and longevity tracking. The core offerings include TruAge™ (epigenetic biological age testing), TruHealth™ (nutritional and systems health testing), and their combined bundle. TruAge measures biological age using proprietary algorithms including OMICmAge™ (developed with Harvard University), DunedinPACE™ (exclusively licensed), and SYMPHONYAge™ (from Yale University), analyzing over 100,000 DNA methylation markers. TruHealth complements this with 105+ biomarkers for nutritional, metabolic, immune, and cognitive health assessment. The platform is CLIA certified, HSA/FSA accepted, and designed for direct-to-consumer use with at-home sample collection kits priced at $499 for TruAge with subscription options available.

Differentiator

Problem solved

Functional benefit

Brands

  • TruAge™: Epigenetic test measuring biological age at the cellular level, including OMICmAge, DunedinPACE, SYMPHONYAge, and various health risk assessments.
  • TruHealth™
  • TruAge + TruHealth™

Products and services

  • TruAge™ Test

Quantifiable outcome

  • 32-week semaglutide study showed average biological age reversal of 3.1 years and 9% slowing of aging rate
  • +1 more outcomes

Companies that use TruDiagnostic

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

TruDiagnostic technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

TruDiagnostic partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship and core.

  • TMRWflagshipChannel Partner/ Reseller/ Distributor · 13 March 2026Exclusive Australian partnership where TMRW longevity platform provides TruDiagnostic's epigenetic testing services to Australian members. TruDiagnostic gains market access while TMRW offers comprehensive longevity diagnostics.
  • Harvard UniversitycoreStrategic or Co-development PartnerCollaborative development of OMICmAge, a multi-omic biological aging biomarker that integrates DNA methylation with proteomic, metabolomic, and clinical data. Partnership leverages Harvard research expertise with TruDiagnostic's proprietary database.
  • Yale UniversitycoreStrategic or Co-development PartnerLicensing and development of SYMPHONYAge clock series providing organ-specific epigenetic aging algorithms across 11 body systems including brain, heart, liver, and lungs.
  • Dunededin Study (University of Otago)coreTechnology or IntegrationExclusively licensed DunedinPACE algorithm from the Dunedin Multidisciplinary Health and Development Study for pace of aging measurement.
  • North Carolina State UniversitycoreStrategic or Co-development PartnerCollaboration to fully characterize all imprinting control regions and develop novel Imprintome epigenetic methylation array for testing.
  • Cornell UniversitycoreStrategic or Co-development PartnerUniversity partnership for research and licensing opportunities in epigenetics and aging research.
  • Duke UniversitycoreStrategic or Co-development PartnerUniversity partnership for research and licensing opportunities in epigenetics and aging research.
  • University Partnerships (20+)coreStrategic or Co-development PartnerActive partnerships with over 20 renowned universities for research collaborations and licensing opportunities in epigenetic science.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

TruDiagnostic competitors and assessment

Company assessment

Direct peers

  • Elysium Health: Elysium's Index product is a direct-to-consumer epigenetic age test built on Illumina EPIC arrays—the closest head-to-head competitor to TruDiagnostic's TruAge. Both compete for the same biohacker and longevity consumer with methylation-based biological age reports.
  • Tally Health: Tally Health offers a consumer longevity membership with biological age testing and clinical protocols. It was acquired by TruDiagnostic in April 2026, but operationally its consumer offering is structurally identical to TruDiagnostic's DTC longevity positioning.
  • NOVOS: NOVOS sells longevity supplements bundled with a biological age testing program including epigenetic measures. It targets the same biohacker and longevity consumer with a combined supplement-and-test value proposition that overlaps with TruDiagnostic's wellness-oriented customer base.
  • GlycanAge: GlycanAge offers a direct-to-consumer biological age test based on immunoglobulin G glycan analysis. It competes for the same longevity-conscious consumer seeking objective biological age measurement, using a complementary but substitutable biomarker approach to DNA methylation.
  • InsideTracker: InsideTracker provides personalized biomarker analysis from blood tests with longevity and performance-oriented dashboards. It competes with TruDiagnostic's TruHealth panel for consumers seeking data-driven health optimization, though its core modality is blood biomarkers rather than epigenetics.

Emerging players

  • Function Health: Function Health offers comprehensive annual blood biomarker testing with a longevity framing and physician-led review. It addresses a similar health-optimization consumer with broader lab panels, making it a partial substitute for TruDiagnostic's premium testing bundles.
  • Viome: Viome sells direct-to-consumer gut microbiome and transcriptomic testing with personalized nutrition recommendations and a 'biological age' framing. It overlaps with TruDiagnostic's preventive-health, multi-omic consumer value proposition though its core analyte is the microbiome.

Broad incumbents

  • Human Longevity Inc. Human Longevity offers whole-genome sequencing, advanced imaging, and comprehensive biomarker panels in a premium executive-health membership. It overlaps with TruDiagnostic's premium longevity diagnostics segment with a broader (and more expensive) clinical-grade offering.
  • Genova Diagnostics: Genova Diagnostics is an established specialty clinical laboratory offering advanced biomarker, genomic, and functional testing through healthcare providers. It competes for TruDiagnostic's healthcare-provider channel with a deeper, more clinically entrenched footprint.

Others

  • Zymo Research: Zymo Research supplies epigenetic research reagents, kits, and services (including DNA methylation arrays and analysis) used by academic and clinical labs. It is an enabling technology provider in the same epigenetic workflow that TruDiagnostic's lab depends on, rather than a direct consumer competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

TruDiagnostic social profiles

Digital presence

TruDiagnostic compliance and trust

Trust signal

Compliance2 records

TruDiagnostic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TruDiagnostic leadership team

Management profile

Number of profiles

Profiles1 record

TruDiagnostic funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TruDiagnostic M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TruDiagnostic

What does TruDiagnostic do?

TruDiagnostic sells at-home epigenetic and biomarker test kits—primarily the TruAge™ biological age test, the TruHealth™ nutritional/biological systems test, and a combined bundle—processed in its CLIA-certified Lexington, Kentucky laboratory using Illumina EPIC array DNA methylation analysis. It also provides B2B clinical laboratory services to healthcare providers, research collaborations to academic institutions, and grant-funded research to develop new epigenetic diagnostic models. The company operates what it describes as the world's largest private DNA methylation dataset and licenses/exclusively licenses proprietary algorithms (OMICmAge, DunedinPACE, SYMPHONYAge) to power its reports.

Is TruDiagnostic a public or private company?

TruDiagnostic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was TruDiagnostic founded?

TruDiagnostic was founded in 2019. It employs 51 to 100 people.

Where is TruDiagnostic based?

TruDiagnostic is headquartered in Lexington, United States, in the North America region.

How does TruDiagnostic make money?

Four revenue lines are on record. Direct-to-Consumer Epigenetic Testing is the primary driver. The others are annual Subscription, healthcare Provider Services and NIH-Funded Research.

Who are TruDiagnostic's main competitors?

Direct peers on record are Elysium Health, Tally Health, NOVOS, GlycanAge and InsideTracker. Emerging players are Function Health and Viome. Broad incumbents are Human Longevity Inc. and Genova Diagnostics. Zymo Research is listed as an others.

Does TruDiagnostic have an API?

Yes. TruDiagnostic offers an API Reference accessible at https://trudiagnostic.notion.site/Tru-Diagnostic-v2-API-100865e61b7e803fa038dee5e55e6cc2 for developers and partners. The API is designed for healthcare providers and commercial partners to programmatically access TruDiagnostic's epigenetic testing services, including data retrieval and programmatic integration capabilities. Developer documentation is at trudiagnostic.notion.site/Tru-Diagnostic-v2-API-100865e61b7e803fa038dee5e55e6cc2.

What industry is TruDiagnostic in?

TruDiagnostic's product category is Epigenetic Testing Services. Its primary akta.pro industry code is HLAGANAF, Epigenomics & Chromatin Profiling Services, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireOnline Platform Lets Patients Order Specialty Lab Tests Without a Doctor’s VisitLab Test Shop, a direct-to-consumer lab testing marketplace, lets patients order specialty tests without a doctor's visit by using a network of 50-state-licensed providers to authorize orders. The platform connects users to over 20 independent specialty labs, excluding New York, New Jersey, and Rhode Island, and does not offer consultations or result interpretation.eWEEKWhy Reproducible Analytics Is Critical for AI in Healthcare and Life SciencesAI adoption in healthcare and life sciences is accelerating, with 66% of physicians now using AI tools according to the American Medical Association, yet reproducibility remains a critical challenge with 72% of biomedical researchers agreeing the field faces a reproducibility crisis that undermines regulatory validation and patient safety. The article profiles TruDiagnostic, an epigenetic testing company that achieved a one-year acceleration in development, 60% reduction in cloud infrastructure costs, and 10x improvement in AI model training performance after adopting Posit's unified analytics platform to address fragmented R and Python workflows. The piece argues that reproducible analytics is essential for ensuring AI-driven clinical and scientific results remain consistent, verifiable, and trustworthy over time.NatureOMICmAge quantifies biological age by integrating multi-omics with electronic medical recordsResearchers developed OMICmAge, a multi-omic biological aging biomarker that integrates DNA methylation with proteomic, metabolomic, and clinical data, using approximately 31,000 participants from the Mass General Brigham Biobank to create three aging measures (EMRAge, DNAmEMRAge, and OMICmAge). The biomarkers demonstrated strong predictive power for mortality, cardiovascular disease, type 2 diabetes, COPD, depression, and cancer across validation cohorts totaling over 36,000 individuals from TruDiagnostic and Generation Scotland. The study establishes OMICmAge as an accessible, scalable measure of biological aging that can be quantified from DNA methylation alone while leveraging multi-omic data through epigenetic biomarker proxies.Longevity.TechnologyTruDiagnostic tops consumer at-home aging test listTech review platform Consumer365 named TruDiagnostic's TruAge Test its top at-home biological age test for 2026, recognizing it for offering structured insights into how different parts of the body are aging in an accessible format for everyday users. The test uses a finger-prick sample analyzed at a certified laboratory to measure molecular patterns linked to aging, delivering results through a digital dashboard that breaks down aging across eleven major organ systems including the heart, brain, immune system, and metabolism. The recognition underscores a broader shift toward consumers seeking data-driven health tracking tools that allow them to monitor and influence the aging process over time.PR NewswireBest At-Home Biological Age Test (2026): TruDiagnostic Named Top Choice for Personalized Longevity Tracking by Consumer365Consumer365 has recognized TruDiagnostic's TruAge Test as a significant option for at-home biological age assessments, emphasizing its capability to provide detailed insights into internal health through the measurement of biological age and organ system performance. The test offers a user-friendly collection process and comprehensive analysis by a certified laboratory, which facilitates monitoring age-related health trends. This recognition aligns with the increasing consumer interest in preventive health and data-driven wellness solutions.PR NewswireBest Pace of Aging Test (2026): TruDiagnostic Recognized for DunedinPace Innovation by Expert ConsumersExpert Consumers recognized TruDiagnostic for its DunedinPace-based at-home aging test during its 2026 assessment of biological-aging diagnostics. The recognition highlights the company's integration of the DunedinPace algorithm with multi-omic analysis to provide dynamic, real-time insights into biological aging rates. This acknowledgment positions TruDiagnostic as a leader in offering consumers actionable data on health trajectories and intervention effectiveness.Longevity.TechnologyTruDiagnostic named best Horvath clock test for 2026 by Better Business AdviceTruDiagnostic has been recognized by Better Business Advice as providing the best Horvath clock biological age testing solution for 2026, based on the company's detailed epigenetic analysis and reporting quality. The TruAge test analyzes over 100,000 DNA methylation markers to provide comprehensive biological age assessments, including organ-specific age patterns and lifestyle impact markers, delivered through an at-home testing kit. The recognition highlights growing industry interest in biological age assessments as a tool for personalized health planning and preventive care, particularly as research increasingly connects epigenetic markers with long-term health outcomes.PR NewswireBest Horvath Clock Test (2026): TruDiagnostic Awarded for Accurate GrimAge and PhenoAge Analysis by Better Business AdviceBetter Business Advice recognized TruDiagnostic in its 2026 assessment of Horvath Clock testing solutions, citing the company's precision and analytical quality in GrimAge and PhenoAge analysis. The evaluation highlighted TruDiagnostic's technical validity, transparency, and use of dense methylation arrays to provide detailed biological aging metrics. This recognition reflects a broader industry trend toward using epigenetic biomarkers for personalized health monitoring and preventive care.GlobeNewswireNature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and BiomarkersSeer, Inc. announced the publication in Nature Genetics of a large genome-wide association study validating its Proteograph Product Suite for proteomic analysis at peptide-level resolution, with the research led by Weill Cornell Medicine–Qatar in collaboration with Harvard Medical School/Brigham and Women’s Hospital and TruDiagnostic. The study analyzed ~1,600 blood samples, detecting 5,753 proteins and identifying 364 protein quantitative trait loci (pQTLs), of which 102 replicated in an independent cohort, while demonstrating that up to one-third of associations reported by affinity-based assays do not replicate without mass spectrometry validation. The findings provide peer-reviewed evidence that the Proteograph’s mass spectrometry approach is essential for distinguishing true biological effects from assay artifacts, strengthening confidence in drug target and biomarker selection for clinical development.Longevity.TechnologyTruDiagnostic awarded best biological age test of 2025TruDiagnostic has been recognised by Expert Consumers as the "Best Biological Age Test (2025)", highlighting its flagship TruAge platform's precision in assessing biological age using advanced epigenetic biomarkers. The test measures over one million CpG methylation sites to evaluate aging pace and organ-system health, though the company notes it is not a diagnostic tool for disease and further longitudinal studies are needed to validate outcomes.